当前位置:首页 > 百科 >  > 正文
245亿巨资涌入!基金经理看好医药板块估值底部 左侧布局、保持耐心
来源:中国基金报)相关标签:医药板块, 估值底部配置, 医药医疗类ETF, 基金经理, 个股优选var color = '';var taglist_div = document.querySelector('.ptg');taglist_div.innerHTML = taglist_div.innerHTML.replace(/,/g,'');var taglist_a = taglist_div.getElementsByTagName('a');var taglist_a_count = taglist_a.length;var tag_color = '#f7acbc|#deab8a|#817936|#444693|#ef5b9c|#7f7522|#2b4490|#f47920|#80752c|#2a5caa|#f05b72|#905a3d|#87843b|#224b8f|#f15b6c|#8f4b2e|#726930|#003a6c|#f8aba6|#87481f|#454926|#102b6a|#f69c9f|#5f3c23|#2e3a1f|#426ab3|#f58f98|#6b473c|#4d4f36|#46485f|#ca8687|#faa755|#b7ba6b|#4e72b8|#f391a9|#fab27b|#b2d235|#181d4b|#bd6758|#f58220|#5c7a29|#1a2933|#d71345|#843900|#bed742|#121a2a|#d64f44|#905d1d|#7fb80e|#0c212b|#d93a49|#8a5d19|#a3cf62|#6a6da9|#b3424a|#8c531b|#769149|#585eaa|#c76968|#826858|#6d8346|#494e8f|#bb505d|#64492b|#78a355|#afb4db|#987165|#ae6642|#abc88b|#9b95c9|#ac6767|#56452d|#74905d|#6950a1|#973c3f|#96582a|#6f60aa|#b22c46|#705628|#1d953f|#867892|#a7324a|#4a3113|#77ac98|#918597|#aa363d|#412f1f|#007d65|#6f6d85|#ed1941|#845538|#84bf96|#594c6d|#f26522|#8e7437|#45b97c|#694d9f|#d2553d|#69541b|#225a1f|#6f599c|#b4534b|#367459|#8552a1|#ef4136|#cd9a5b|#007947|#543044|#c63c26|#cd9a5b|#40835e|#63434f|#f3715c|#b36d41|#2b6447|#7d5886|#a7573b|#df9464|#005831|#401c44|#aa2116|#b76f40|#006c54|#472d56|#b64533|#ad8b3d|#375830|#45224a|#b54334|#dea32c|#274d3d|#411445|#853f04|#d1923f|#375830|#4b2f3d|#840228|#c88400|#27342b|#402e4c|#7a1723|#c37e00|#65c294|#c77eb5|#a03939|#c37e00|#73b9a2|#ea66a6|#8a2e3b|#e0861a|#72baa7|#f173ac|#8e453f|#ffce7b|#005344|#8f4b4a|#fcaf17|#122e29|#892f1b|#ba8448|#293047|#6b2c25|#896a45|#00ae9d|#733a31|#76624c|#508a88|#54211d|#6d5826|#70a19f|#78331e|#ffc20e|#50b7c1|#53261f|#fdb933|#00a6ac|#999d9c|#f15a22|#d3c6a6|#a1a3a6|#b4533c|#c7a252|#008792|#9d9087|#84331f|#dec674|#94d6da|#8a8c8e|#f47a55|#b69968|#74787c|#f15a22|#c1a173|#5e7c85|#7c8577|#f3704b|#76becc|#72777b|#da765b|#ffd400|#77787b|#c85d44|#ffd400|#009ad6|#4f5555|#ae5039|#145b7d|#6c4c49|#6a3427|#11264f|#563624|#8f4b38|#7bbfea|#3e4145|#8e3e1f|#decb00|#33a3dc|#3c3645|#f36c21|#cbc547|#228fbd|#464547|#b4532a|#6e6b41|#2468a2|#130c0e|#b7704f|#596032|#2570a1|#281f1d|#de773f|#525f42|#2585a6|#2f271d|#c99979|#5f5d46|#1b315e|#1d1626'.split('|');var tag_color_count = tag_color.length;for(var i=0; i 版权声明:该帖版权归原文作者所有,仅代表该作者观点,如有侵权,请点击此处查看处理方式。 收藏1关注打赏分享 点赞 0 举报 function jizan(tid, that) { jq.ajax({ url: 'plugin.php?id=huozan&mod=ajax', data:{ 'id': 'huozan', 'mod': 'ajax', 'tid': tid, }, type:'post', dataType:'json', timeout : 5000, success: function(data) { alert(data.msg); if (data.state == 1) { window.location.href = 'https://passport.55188.com/index/login?referer=https%3A%2F%2Fwww.55188.com%2Fthread-10665784-1-1.html'; } else if (data.state == 2) { window.location.href = 'https://passport.55188.com/index/oauth?dotype=link&type=weixin'; } else if (data.state == 4) { jq(that).html('已点赞'+ data.huozan_num +''); } else if (data.state == 3) { jq(that).html('点赞'+ data.huozan_num +''); } } }); }     #禁止发布QQ、微信、手机、邮箱、外链等任何形式的联系方式。#快速回复 .m-about-stock{padding:10px;border:1px solid #e7e7e7;background:#fafafa;border-radius:4px;}.m-about-stock .xl2 li{width:auto;margin:2px 5px;height:auto;line-height:1.8;}.m-about-stock .xl2 li a{color:#369;font-weight:bold;}.m-about-stock .xl2 li a span{padding-left:3px;color:#808080;font-weight:normal;}相关股票创新医疗002173  时间:2023-05-08 08:45:17
字号:


(资料图片)

看好医药板块的估值底部配置价值,今年已有近245亿元的资金涌入医药医疗类ETF,份额猛增超421亿份。同时,有13只医药主题基金通过优选个股和景气子行业,今年取得了10%以上的收益率,表现最好的收益达39.45%;但也有16只医药基金今年仍亏超10%,分化明显。基金经理认为,医药板块基本面复苏,叠加估值压力充分消化,预计今年表现会好于去年。对于投资者来说,左侧积极布局,并保持耐心,长期能够享受行业发展红利。

看好基本面回暖、估值性价比

" file="https://attachment.55188.com/forum/202305/08/075640ub6q650x6uf5uxyg.png?imageMogr2/thumbnail/815x1024>" inpost="1"/>

fakename.png (99.33 KB, 下载次数: 0)

下载附件

2023-5-8 07:56 上传

标签: